Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:08 AM
Ignite Modification Date:
2025-12-25 @ 4:08 AM
NCT ID:
NCT03216720
Eligibility Criteria:
Inclusion Criteria:
* Non-emergent CABG with ECC
* Current use of low-dose acetylsalicylic acid
* Agreement of eligibility by the multidisciplinary heart team
Exclusion Criteria:
* Inability to give informed consent
* Emergent treatment required (\< 24 hours)
* Concomitant cardiac surgery
* Previous cardiac surgery
* Severely reduced kidney function (eGFR \< 30ml/min/1.73m2 or on dialysis)
* Severely reduced ejection fraction (EF \< 45%)
* Diagnosis of bleeding disorders
* Non-aspirin antiplatelet drugs stopped \< 5 days preoperatively (Clopidogrel, Prasugrel, Ticagrelor, Ticlopidine)
* Current use of systemic glucocorticoid therapy
* Current use of vitamin K antagonists or new oral non-vitamin K anticoagulants
* Platelet count \> 450 or \<100 x 109/l prior to surgery
* Pregnant women or women of child bearing potential without negative pregnancy test
* Active participant in any other intervention trial
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Maximum Age:
100 Years
Study:
NCT03216720
Study Brief:
Protocol Section:
NCT03216720